An old off-pump coronary artery bypass surgeon's reflections:A retrospective by Angelini, Gianni D
                          Angelini, G. D. (2019). An old off-pump coronary artery bypass surgeon's
reflections: A retrospective. Journal of Thoracic and Cardiovascular
Surgery, 157(6), 2274-2277. https://doi.org/10.1016/j.jtcvs.2018.09.086
Peer reviewed version
License (if available):
CC BY-NC-ND
Link to published version (if available):
10.1016/j.jtcvs.2018.09.086
Link to publication record in Explore Bristol Research
PDF-document
This is the accepted author manuscript (AAM). The final published version (version of record) is available online
via Elsevier at https://doi.org/10.1016/j.chest.2018.11.026 . Please refer to any applicable terms of use of the
publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/pure/user-
guides/explore-bristol-research/ebr-terms/
 1 
 
An old off pump coronary artery bypass surgeon’s reflexions: a “retrospective”  
Gianni D Angelini MD, MCh, FRCS, FMed Sci 
Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, 
 
United Kingdom. 
 
Address for correspondence: Professor Gianni D. Angelini, MD, MCh, FRCS, FMed Sci  
 
Level 7, Queen’s Building, 
 
Bristol Heart Institute, Bristol Royal Infirmary, Marlborough St, Bristol,  
 
United Kingdom BS2 8HW (E-mail: g.d.angelini@bristol.ac.uk). 
 
The author has no conflict of interest to report. 
 
No funding was provided for this work. 
 
Words count 1589 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 2 
 
Central message 
After practising OPCAB for 25 years I am reaching the twilight of my surgical career. From 
this perspective, I reflect on this experience and offer some insights which I hope will be of 
help to the surgical community, particularly to the young surgeons in training. 
 
Introduction 
In 2010 at the height of the off pump coronary artery bypass (OPCAB) surgery controversy, I 
wrote an editorial for this journal with one of my trainees, the goal of which was critically to 
evaluate the status of the technique and its future direction (1). We concluded that OPCAB 
was a safe alternative to on pump coronary artery bypass (ONCAB) surgery and, with proper 
structured training and supervision and in the right environment, OPCAB was a technique 
“for the many and not the few”. 
After practising OPCAB for 25 years I am reaching the twilight of my surgical career. From 
this perspective, I reflect on this experience and offer some insights which I hope will be of 
help to the surgical community, particularly to the young surgeons in training. 
Early stage development 
With colleagues, my journey started in 1994, when the aim was to emulate our fellow general 
surgeons practising minimally invasive surgery. The goal was to revascularize the left 
anterior descending (LAD) coronary artery with the left internal mammary artery (LIMA) via 
a left anterior small thoracotomy (LAST) (2). By default, the restricted access led to the 
surgery been performed on the beating heart. Although I had practised endoscopic thoracic 
surgery during my training, I was not accustomed to working in a confined space, and this 
combined with the lack of dedicated instruments sometimes made the surgery impossible. 
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To increase the proportion of patients to whom LAST could be applied, the hybrid approach 
was devised with percutaneous coronary intervention (PCI) plus or minus stenting (2). 
However, the simultaneous combination, which required using anticoagulation after stenting, 
was often followed by bleeding from the surgical site.  Carrying out PCI before surgery did 
not allow the quality of the surgery to be checked. PCI a few days after surgery did not help 
in the event of a problem with the LIMA-LAD anastomosis. Furthermore, most health service 
providers charged for two separate procedures, with significant increase in costs. 
We soon realised that to revascularize all the ischemic areas of the heart we had to go back to 
the experience of surgeons like Buffalo and Benetti in the late 1980s, i.e. beating heart 
coronary surgery via a median sternotomy (3). Ironically, this rejected the quest for a 
minimally invasive approach and, instead, prioritised the perceived benefits of avoiding the 
cardiopulmonary bypass (CPB).  
In our institution, a dedicated group including anaesthetists, nurses and surgeons embarked 
on a structured program which resulted in an increase in OPCAB from 8% of CABG 
operations in 1997 to 72% in 2003 without any increase in procedural morbidity. In relation 
to the learning curve, after 100 OPCAB operations, performance was the same or better for 
the residents in training as for the senior consultant (GDA). For all surgeons, performance 
was the same or better for OPCAB than ONCAB grafting (4). However, together with many 
other centres during the early phase, we contributed to the main Achilles’ heel of OPCAB, 
i.e. “incomplete revascularization”. We were in denial, describing vessels we could not graft 
because of technical difficulty as being too small or not important. Furthermore, the 
worldwide excitement of doing pioneering work, and the belief that avoiding CPB was the 
key to all our problems, resulted in an uncritical and excessive use of the technique. 
The evidence 
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Early single-centre both retrospective and randomized clinical studies (RCT) from units who 
had adopted enthusiastically OPCAB reported no difference between OPCAB and ONCAB 
in the 30-day composite outcome of death or complications (reoperation, new mechanical 
support, cardiac arrest, coma, stroke, or renal failure), or at long term follow-up (5-7). These 
were followed by numerous randomized trials, meta-analyses and retrospective case series 
which failed to prove a clear superiority of one technique over the other in the short-term. 
However, in most of these studies there was a reduced incidence of early in hospital 
complications like atrial fibrillation, renal and respiratory failure and requirement for blood 
products among patients who had OPCAB compared to those who had ONCAB (5,6,8-12). 
Conversely, OPCAB patients generally received a lower average number of grafts resulting 
in a higher incidence of incomplete revascularization and need for repeat revascularization. 
This is likely to have impacted on long-term survival although contradictory results have 
been reported (7,11-15). 
These findings led to the question: should OPCAB be performed by a dedicated team 
available in every institution like for mitral valve repair and major aortic surgery, or should it 
be part of routine clinical practise in the armamentarium of every surgeon?  
OPCAB: for the many or the few? 
OPCAB is a technically demanding and more difficult technique to master than ONCAB. In 
my opinion (although this may sound controversial and immodest) it requires more than 
average surgical dexterity. In my career, I have seen trainees and senior surgeons struggling 
to perform a coronary anastomosis on CPB and on an arrested heart. OPCAB also requires a 
different state of mind, since the operator does not have the CPB machine to fall back on. A 
good OPCAB surgeon is one who knows when it is time to convert to ONCAB, giving plenty 
of warning to the perfusion team, and well before the haemodynamic status deteriorates and 
 5 
 
the heart arrests. A similar decision should be taken with no shame when complete 
revascularization cannot be achieved with OPCAB. Unplanned conversion dramatically 
increases the risk of peri-operative complications hospital cost and mortality (16-17).  
The role of experience is illustrated by the broad simple index of the rate of conversion.  In 
the STS database the conversion rate over 196,000 patients was 5.5% of which 50% were 
elective (18).    In the ROOBY trial (11) the rate of conversion was 12.5% (surgeons took 
part regardless of their experience and 55% of the procedures were performed by surgeons in 
training).  Even in the CORONARY trial (10) in which surgeons were required to have 
performed 100 OPCAB procedures before been allowed to recruit, the conversion rate was 
7.9%. In a post-hoc analysis of the ART trial including 1260 OPCAB and 1700 ONCAB 
patients, “sporadic” OPCAB surgeons (1-5 procedures) had a higher rate of conversion 
(12.9%) than “high volume” OPCAB surgeons, and a higher rate of operative mortality 
(4.8%) when compared to ONCAB despite a similar distribution of risk factors. OPCAB 
performed by 3 high-volume OPCAB surgeons (>60) showed very low conversion rate (1%) 
and the 5-year mortality of OPCAB performed by 95 “OPCAB only” surgeons (outside the 
trial) was comparable to ONCAB (19).  
These observations highlight that one of the reasons for the conflicting results reported in the 
literature may arise simply because of comparing a well long term established technique, i.e. 
ONCAB (part of any trainee curriculum and surgeon main practise) with a relatively new 
procedure, OPCAB, carried out by enthusiastic but insufficiently experienced or 
“occasional” surgeons. 
Acquiring proficiency in OPCAB requires a learning curve and experienced trainers in a 
dedicated institution. Except for a few dedicated units which offer fellowship training to the 
best of my knowledge there are no national societies which have included OPCAB in the 
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training curriculum. The perception that success with the technique is limited to more 
proficient surgeons, and a fear of deleterious patient outcomes, especially during the learning 
curve is also deterring young surgeons to adopt the technique. This is particularly relevant in 
the United Kingdom where the results of cardiac surgery units and individual surgeons are 
published and made available to the public. Furthermore, the fear of name and shame and the 
potential of negative repercussions on private practice are also important considerations. 
The controversy about routine use of OPCAB is not dissimilar from arterial revascularization 
in CABG; a technique embraced by a few dedicated surgeons, failed to be adopted into routine 
clinical practice. Is this as often advocated because of lack of clear evidence of superiority or 
simply because it is a technically demanding technique with all the same potential problems 
described above for OPCAB? 
Currently, in the US and Europe OPCAB is used in roughly 20-25% of patients, whereas in 
India and Japan is the most common strategy. It has been suggested that in India uptake has 
been driven by economic considerations whereas in Japan it may be because surgeons have 
traditionally embraced the most advanced technique like total arterial coronary 
revascularization. A more hierarchic structure may also play a role in deciding what surgical 
strategy a unit will adopt, contrary to the United Kingdom where every senior surgeon is to a 
degree their own master. 
Conclusion 
When performed by experienced surgeons in centres with the right infrastructure, OPCAB is 
a safe alternative to ONCAB regardless of the patients’ risk profile, and it is associated with 
reduction of hospital early complications and similar long-term outcomes. OPCAB should 
always aim to achieve complete myocardial revascularization and be converted to ONCAB if 
for any technical reason this cannot be achieved. There is a body of evidence in the literature 
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linking poor outcome in OPCAB to surgeons’ limited experience and low volume centres. 
OPCAB is a challenging technique requiring a steep “learning curve”. To master the learning 
curve a team approach is of paramount importance. This would be helped by the introduction 
of specialization in the training curriculum as is the case for mitral valve repair and major 
aortic surgery. Established recognised OPCAB units should be identified to provide training 
fellowships. Recognised OPCAB teams could then select trainees with the right dexterity and 
attitude to facilitate the uptake of OPCAB.  
At present OPCAB surgery should be a specialized practise for the few with the potential to 
become for the many given the right commitment to training. 
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Legend to Figure 
Evolution in stabilization and positioning in 25 years of OPCAB surgery 
A) Stabilisation by means of tapes and snaring of the coronary artery  
B) Pressure stabilizer 
C) Pressure suction stabilizer and heart positioning device 
 
 
 
 
 
 
 
